VINORELBINE PIERRE FABRE vinorelbine 10mg/mL (as tartrate) injection vial

מדינה: אוסטרליה

שפה: אנגלית

מקור: Department of Health (Therapeutic Goods Administration)

מרכיב פעיל:

vinorelbine tartrate, Quantity: 13.85 mg/mL (Equivalent: vinorelbine, Qty 10 mg/mL)

זמין מ:

Pierre Fabre Australia Pty Ltd

טופס פרצבטיות:

Injection, concentrated

הרכב:

Excipient Ingredients: water for injections

מסלול נתינה (של תרופות):

Intravenous

יחידות באריזה:

10 x 1ML, 1 x 1mL

סוג מרשם:

(S4) Prescription Only Medicine

סממני תרפויטית:

Vinorelbine Pierre Fabre is indicated for the treatment of advanced breast cancer after failure of standard therapy, as a single agent or in combination; and as first line treatment for advanced non-small cell lung cancer, as a single agent or in combination. Vinorelbine Pierre Fabre is indicated for the treatment, in combination with cisplatin, of patients with completely resected non-small cell lung cancer of stage IB or greater.

leaflet_short:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

מצב אישור:

Licence status A

תאריך אישור:

2000-08-04